MedTrace Logo

Molecular Biomarkers in Renal Transplantation Via TruGraf® Test

NCT04398498 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-08-19

No results posted yet for this study

Summary

The TruGraf® test is a non-invasive blood test that measures molecular gene expression profiles associated with clinical conditions previously only diagnosed by biopsy in kidney transplant recipients. The results of the TruGraf test provide additional information about the adequacy of immunosuppression and may be used to support decisions in patient management.

Conditions

  • Kidney Transplant Rejection

Interventions

DIAGNOSTIC_TEST

Diagnostic Test: TruGraf® Testing

5 mL collection PAXgene blood sample

Sponsors & Collaborators

  • Scripps Health

    collaborator OTHER

  • Transplant Genomics, Inc.

    lead INDUSTRY

Principal Investigators

  • Patty West-Thielke, PharmD · Transplant Genomics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04398498 on ClinicalTrials.gov